Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Cilostazol, identified by CAS number 73963-72-1, is a crucial pharmaceutical raw material widely recognized for its therapeutic properties. As a selective phosphodiesterase 3 (PDE3) inhibitor, its primary function is to prevent platelet aggregation and promote vasodilation. These actions make it indispensable in the treatment of conditions characterized by impaired blood flow, most notably intermittent claudication caused by peripheral arterial disease.
NINGBO INNO PHARMCHEM CO.,LTD. is pleased to offer high-quality Cilostazol raw material to the global pharmaceutical industry. Our product is supplied as a fine white to off-white crystalline powder, meeting rigorous specifications essential for pharmaceutical applications. We understand the critical need for purity and consistency in active pharmaceutical ingredients (APIs), and our manufacturing processes adhere to stringent quality control standards.
The Cilostazol raw material available from NINGBO INNO PHARMCHEM CO.,LTD. boasts a purity level typically exceeding 98%, with specifications ranging from 98.0% to 102.0%. We employ advanced analytical techniques, such as High-Performance Liquid Chromatography (HPLC), to verify the purity and quality of each batch. Our commitment to quality ensures that our Cilostazol meets international pharmaceutical standards, providing reliability for downstream manufacturing processes.
The chemical structure of Cilostazol is represented by the molecular formula C20H27N5O2, with a molecular weight of 369.461. This well-defined structure underlies its specific pharmacological activity. Supplied as a pharmaceutical grade material, it is suitable for use in various drug formulations aimed at improving patient outcomes in cardiovascular and peripheral vascular diseases.
Procuring high-quality pharmaceutical raw materials is paramount for drug manufacturers. Companies seeking a reliable Cilostazol manufacturer or a trusted Cilostazol supplier will find NINGBO INNO PHARMCHEM CO.,LTD. a capable partner. We maintain robust production capacities and efficient supply chain logistics to meet the demands of our clients globally.
For pharmaceutical companies looking to buy Cilostazol or purchase Cilostazol raw material, NINGBO INNO PHARMCHEM CO.,LTD. offers competitive options. Factors influencing the Cilostazol price include order volume, packaging requirements, and specific quality certifications needed. We encourage interested parties to reach out to discuss their specific needs and obtain detailed product information and pricing.
Our commitment extends beyond just supplying the material; we strive to provide comprehensive support regarding product specifications, handling, and relevant documentation. Choosing NINGBO INNO PHARMCHEM CO.,LTD. as your source for Cilostazol raw material ensures access to a product manufactured under controlled conditions, designed for optimal performance in pharmaceutical applications. We are dedicated to facilitating the development and production of effective medications by providing essential, high-quality active ingredients.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
